Jefferies Raises Price Target on Vertex Pharma (VRTX) to $107; Reiterates Buy

July 28, 2016 9:07 AM

Jefferies reiterated a Buy rating on Vertex Pharma (NASDAQ: VRTX), and raised the price target to $107.00 (from $102.00), following ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found